Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

PlexusDx vs PrideRx

PlexusDx
Graded #162

Higher grade

vs+12
PrideRx
Graded #435

Lower grade

The verdict

PlexusDx takes it — 67.7/100 to 55.7/100.

PlexusDx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. PlexusDx (plexusdx.com) is a US GLP-1 telehealth platform offering compounded weight-loss medications with licensed providers in all 50 states.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePlexusDx +54
74
20
Dose & formulationPrideRx +19
64
83
Clinical oversightEven
74
74
Labs & monitoringPrideRx +1
52
53
FulfillmentPlexusDx +11
78
67
Contract termsPlexusDx +14
55
41
PlexusDx · left barPrideRx · right bar

The numbers

MetricPlexusDxPrideRx
WeighScore67.7/10055.7/100
GradeCC
Scorecard rank#162#435
Semaglutide$149/mo (starting dose, compounded)$149/mo (starting dose, plus a separate fee, brand-name)
Tirzepatide$249/mo (starting dose, compounded)$299/mo (2.5 mg dose, plus a separate fee, brand-name)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
PlexusDx

Graded #162 · C

Strengths

  • Licensed providers available in all 50 states
  • Range of options including low-cost microdose GLP-1 from $129/mo
  • Optional Precision Peptide genetic panel adds a personalization angle
  • Independent clinician review via state-licensed telehealth platform
  • Compounded medications from state-licensed pharmacies

Where it loses points

  • Compounded medications only; no FDA-approved brand options
  • Specific compounding pharmacies not named
  • Genetic-panel upsell may not add clinical value for everyone
  • Tirzepatide pricing from $249/mo is higher than budget rivals
  • No insurance accepted
PrideRx

Graded #435 · C

Strengths

  • All three brand-name GLP-1 options on one platform — Zepbound injection, Wegovy Pill, and Foundayo — no compounded substitutes
  • Medication ships from and is billed by LillyDirect or NovoCare; PrideRx never handles or re-sells the drug
  • Transparent published per-dose pricing with on-page verification dates
  • $99/mo membership includes doctor visits and prescription management; 24-hour prescription review

Where it loses points

  • $99/mo membership on top of medication cost — all-in runs $248–$548/mo depending on drug and dose
  • Legal entity and prescribing medical group are not named on the site
  • No LegitScript certification visible
  • State availability is not published — telehealth consult rules vary by state

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard